AstraZeneca S.A. de C.V. - Søgeresultater

Den Europæiske Union - dansk - EMA (European Medicines Agency)

tezspire

astrazeneca ab - tezepelumab - astma - medicin for obstruktiv sygdomme, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

imjudo

astrazeneca ab - tremelimumab - carcinoma, hepatocellular - antineoplastiske midler - imjudo in combination with durvalumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc). imjudo in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

bricanyl 0,5 mg/ml injektionsvæske, opløsning

astrazeneca a/s - terbutalinsulfat - injektionsvæske, opløsning - 0,5 mg/ml

Den Europæiske Union - dansk - EMA (European Medicines Agency)

imfinzi

astrazeneca ab - durvalumab - carcinom, ikke-småcellet lunge - antineoplastiske midler - non-small cell lung cancer (nsclc)imfinzi as monotherapy is indicated for the treatment of locally advanced, unresectable non small cell lung cancer (nsclc) in adults whose tumours express pd-l1 on ≥ 1% of tumour cells and whose disease has not progressed following platinum based chemoradiation therapy (see section 5. imfinzi in combination with tremelimumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic nsclc with no sensitising egfr mutations or alk positive mutations. small cell lung cancer (sclc)imfinzi in combination with etoposide and either carboplatin or cisplatin is indicated for the first-line treatment of adults with extensive-stage small cell lung cancer (es-sclc). biliary tract cancer (btc)imfinzi in combination with gemcitabine and cisplatin is indicated for the first line treatment of adults with unresectable or metastatic biliary tract cancer (btc). hepatocellular carcinoma (hcc)imfinzi in combination with tremelimumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc).

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

plendil 10 mg depottabletter

astrazeneca a/s - felodipin - depottabletter - 10 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

plendil 2,5 mg depottabletter

astrazeneca a/s - felodipin - depottabletter - 2,5 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

plendil 5 mg depottabletter

astrazeneca a/s - felodipin - depottabletter - 5 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

spirocort 0,5 mg/ml inhalationsvæske til nebulisator, suspension

astrazeneca a/s - budesonid - inhalationsvæske til nebulisator, suspension - 0,5 mg/ml